Vaccinations in children with cancer

Susanna Esposito, Valerio Cecinati, Letizia Brescia, Nicola Principi

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Children with cancer may be immunocompromised as a result of their primary underlying disease and/or the use of prolonged and intensive chemotherapy administered with or without irradiation. The damage to the immune system varies with the age of the patient, the type of cancer, and the intensity of the chemotherapy used to treat it. This review analyses the data regarding the immunogenicity, efficacy, safety and tolerability of the vaccines usually recommended in the first years of life in order to help pediatricians choose the best immunisation programme against vaccine-preventable disease in children with cancer receiving standard-dose chemotherapy. Areas for future research are highlighted because new data are required to be able to draw up evidence-based recommendations that will ensure adequate protection against infectious diseases in such high-risk children.

Original languageEnglish
Pages (from-to)3278-3284
Number of pages7
JournalVaccine
Volume28
Issue number19
DOIs
Publication statusPublished - Apr 26 2010

Fingerprint

drug therapy
Vaccination
vaccination
Drug Therapy
neoplasms
Vaccines
pediatricians
vaccines
Neoplasms
Immunization Programs
infectious diseases
Communicable Diseases
immune system
Immune System
immunization
irradiation
immune response
Safety
dosage
Pediatricians

Keywords

  • Cancer
  • Children
  • Prevention
  • Vaccination
  • Vaccines

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Cite this

Esposito, S., Cecinati, V., Brescia, L., & Principi, N. (2010). Vaccinations in children with cancer. Vaccine, 28(19), 3278-3284. https://doi.org/10.1016/j.vaccine.2010.02.096

Vaccinations in children with cancer. / Esposito, Susanna; Cecinati, Valerio; Brescia, Letizia; Principi, Nicola.

In: Vaccine, Vol. 28, No. 19, 26.04.2010, p. 3278-3284.

Research output: Contribution to journalArticle

Esposito, S, Cecinati, V, Brescia, L & Principi, N 2010, 'Vaccinations in children with cancer', Vaccine, vol. 28, no. 19, pp. 3278-3284. https://doi.org/10.1016/j.vaccine.2010.02.096
Esposito S, Cecinati V, Brescia L, Principi N. Vaccinations in children with cancer. Vaccine. 2010 Apr 26;28(19):3278-3284. https://doi.org/10.1016/j.vaccine.2010.02.096
Esposito, Susanna ; Cecinati, Valerio ; Brescia, Letizia ; Principi, Nicola. / Vaccinations in children with cancer. In: Vaccine. 2010 ; Vol. 28, No. 19. pp. 3278-3284.
@article{d75ad11383e7458099cd73d9fc40db58,
title = "Vaccinations in children with cancer",
abstract = "Children with cancer may be immunocompromised as a result of their primary underlying disease and/or the use of prolonged and intensive chemotherapy administered with or without irradiation. The damage to the immune system varies with the age of the patient, the type of cancer, and the intensity of the chemotherapy used to treat it. This review analyses the data regarding the immunogenicity, efficacy, safety and tolerability of the vaccines usually recommended in the first years of life in order to help pediatricians choose the best immunisation programme against vaccine-preventable disease in children with cancer receiving standard-dose chemotherapy. Areas for future research are highlighted because new data are required to be able to draw up evidence-based recommendations that will ensure adequate protection against infectious diseases in such high-risk children.",
keywords = "Cancer, Children, Prevention, Vaccination, Vaccines",
author = "Susanna Esposito and Valerio Cecinati and Letizia Brescia and Nicola Principi",
year = "2010",
month = "4",
day = "26",
doi = "10.1016/j.vaccine.2010.02.096",
language = "English",
volume = "28",
pages = "3278--3284",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "19",

}

TY - JOUR

T1 - Vaccinations in children with cancer

AU - Esposito, Susanna

AU - Cecinati, Valerio

AU - Brescia, Letizia

AU - Principi, Nicola

PY - 2010/4/26

Y1 - 2010/4/26

N2 - Children with cancer may be immunocompromised as a result of their primary underlying disease and/or the use of prolonged and intensive chemotherapy administered with or without irradiation. The damage to the immune system varies with the age of the patient, the type of cancer, and the intensity of the chemotherapy used to treat it. This review analyses the data regarding the immunogenicity, efficacy, safety and tolerability of the vaccines usually recommended in the first years of life in order to help pediatricians choose the best immunisation programme against vaccine-preventable disease in children with cancer receiving standard-dose chemotherapy. Areas for future research are highlighted because new data are required to be able to draw up evidence-based recommendations that will ensure adequate protection against infectious diseases in such high-risk children.

AB - Children with cancer may be immunocompromised as a result of their primary underlying disease and/or the use of prolonged and intensive chemotherapy administered with or without irradiation. The damage to the immune system varies with the age of the patient, the type of cancer, and the intensity of the chemotherapy used to treat it. This review analyses the data regarding the immunogenicity, efficacy, safety and tolerability of the vaccines usually recommended in the first years of life in order to help pediatricians choose the best immunisation programme against vaccine-preventable disease in children with cancer receiving standard-dose chemotherapy. Areas for future research are highlighted because new data are required to be able to draw up evidence-based recommendations that will ensure adequate protection against infectious diseases in such high-risk children.

KW - Cancer

KW - Children

KW - Prevention

KW - Vaccination

KW - Vaccines

UR - http://www.scopus.com/inward/record.url?scp=77950492235&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950492235&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2010.02.096

DO - 10.1016/j.vaccine.2010.02.096

M3 - Article

C2 - 20226246

AN - SCOPUS:77950492235

VL - 28

SP - 3278

EP - 3284

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 19

ER -